Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Phyllis J Goodman

Showing results (91-100 of 157) with videos related to

Pageof 16
Sort By:
The Prostate|May 21, 2016
Adding genetic risk score to family history identifies twice as many high-risk men for prostate cancer: Results from the prostate cancer prevention trialHaitao Chen, Xu Liu, Charles B Brendler, et al.
The Prostate|March 21, 2017
Association between variants in genes involved in the immune response and prostate cancer risk in men randomized to the finasteride arm in the Prostate Cancer Prevention TrialDanyelle A Winchester, Cathee Till, Phyllis J Goodman, et al.
The Prostate|January 16, 2016
Key genes involved in the immune response are generally not associated with intraprostatic inflammation in men without a prostate cancer diagnosis: Results from the prostate cancer prevention trialDanyelle A Winchester, Bora Gurel, Cathee Till, et al.
Cancer Prevention Research (Philadelphia, Pa.)|June 26, 2020
Use of Aspirin and Statins in Relation to Inflammation in Benign Prostate Tissue in the Placebo Arm of the Prostate Cancer Prevention TrialLauren M Hurwitz, Ibrahim Kulac, Berrak Gumuskaya, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|July 17, 2014
Factors associated with adherence to an end-of-study biopsy: lessons from the prostate cancer prevention trial (SWOG-Coordinated Intergroup Study S9217)Ellen R Gritz, Kathryn B Arnold, Carol M Moinpour, et al.
The Prostate|June 6, 2015
Variation in genes involved in the immune response and prostate cancer risk in the placebo arm of the Prostate Cancer Prevention TrialDanyelle A Winchester, Cathee Till, Phyllis J Goodman, et al.
Cancer Causes & Control : CCC|June 14, 2011
Serum estrogen levels and prostate cancer risk in the prostate cancer prevention trial: a nested case-control studySong Yao, Cathee Till, Alan R Kristal, et al.
Urology|March 4, 2015
Effect of finasteride on serum androstenedione and risk of prostate cancer within the prostate cancer prevention trial: differential effect on high- and low-grade diseaseAshraful Hoque, Song Yao, Cathee Till, et al.
Cancers|April 23, 2022
Intake Patterns of Specific Alcoholic Beverages by Prostate Cancer StatusHui-Yi Lin, Tung-Sung Tseng, Xinnan Wang, et al.
JAMA|October 13, 2011
Vitamin E and the risk of prostate cancer: the Selenium and Vitamin E Cancer Prevention Trial (SELECT)Eric A Klein, Ian M Thompson, Catherine M Tangen, et al.
Pageof 16

Showing results (91-100 of 157) with videos related to

Sort By:
Pageof 16
The Prostate|May 21, 2016
Adding genetic risk score to family history identifies twice as many high-risk men for prostate cancer: Results from the prostate cancer prevention trialHaitao Chen, Xu Liu, Charles B Brendler, et al.
The Prostate|March 21, 2017
Association between variants in genes involved in the immune response and prostate cancer risk in men randomized to the finasteride arm in the Prostate Cancer Prevention TrialDanyelle A Winchester, Cathee Till, Phyllis J Goodman, et al.
The Prostate|January 16, 2016
Key genes involved in the immune response are generally not associated with intraprostatic inflammation in men without a prostate cancer diagnosis: Results from the prostate cancer prevention trialDanyelle A Winchester, Bora Gurel, Cathee Till, et al.
Cancer Prevention Research (Philadelphia, Pa.)|June 26, 2020
Use of Aspirin and Statins in Relation to Inflammation in Benign Prostate Tissue in the Placebo Arm of the Prostate Cancer Prevention TrialLauren M Hurwitz, Ibrahim Kulac, Berrak Gumuskaya, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|July 17, 2014
Factors associated with adherence to an end-of-study biopsy: lessons from the prostate cancer prevention trial (SWOG-Coordinated Intergroup Study S9217)Ellen R Gritz, Kathryn B Arnold, Carol M Moinpour, et al.
The Prostate|June 6, 2015
Variation in genes involved in the immune response and prostate cancer risk in the placebo arm of the Prostate Cancer Prevention TrialDanyelle A Winchester, Cathee Till, Phyllis J Goodman, et al.
Cancer Causes & Control : CCC|June 14, 2011
Serum estrogen levels and prostate cancer risk in the prostate cancer prevention trial: a nested case-control studySong Yao, Cathee Till, Alan R Kristal, et al.
Urology|March 4, 2015
Effect of finasteride on serum androstenedione and risk of prostate cancer within the prostate cancer prevention trial: differential effect on high- and low-grade diseaseAshraful Hoque, Song Yao, Cathee Till, et al.
Cancers|April 23, 2022
Intake Patterns of Specific Alcoholic Beverages by Prostate Cancer StatusHui-Yi Lin, Tung-Sung Tseng, Xinnan Wang, et al.
JAMA|October 13, 2011
Vitamin E and the risk of prostate cancer: the Selenium and Vitamin E Cancer Prevention Trial (SELECT)Eric A Klein, Ian M Thompson, Catherine M Tangen, et al.
Pageof 16